Drug development

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

The latest advancements driving neuroscience drug discovery

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Data science #Drug development #Drug discovery #Lab automation #Lab technology #Personalised medicine #Pharmaceuticals

New podcast: How technology is impacting drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and… Read More

#News

#Bioactive proteins #Drug development #Drug discovery #Plant-based #Synthetic biology #Tokyo University of Science

New way to synthesise bioactive compounds for drug discovery

Researchers at Tokyo University of Science have successfully developed a new method to synthesise eutyscoparol A and violaceoid C, two naturally occurring compounds with promising antimalarial and antibacterial properties. The new approach involves the synthesis of these compounds using readily available dinitriles. This method requires fewer… Read More

#News

#AI / data analytics / healthtech / informatics #Biotech #Drug development #Drug discovery

Rethinking the pharma R&D lifecycle with AI in mind

Ashu Singhal and Sajith Wickramasekara, co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Drug discovery has quickly become a trendy place to apply AI. Read More

#Exclusive Content

Heart
#AstraZeneca #Clinical trials #Drug development #Drug discovery #Heart failure

Early diagnosis and intervention in heart failure

Heart failure is a collection of different diseases, which can be hard to define and treat through routine clinical practice. Heart failure affects 64 million people globally and approximately half of patients with heart failure die within five years of diagnosis. Real-world data presented at the European Society of Cardiology’s… Read More

#Exclusive Content

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Cancer cell
#AACR #Antibody drug conjugate (ADC) #Cancer research #Drug development #Drug discovery #Zymeworks

Finding protein therapeutics for cancer treatment  

The American Association of Cancer Research (AACR) Annual Meeting took place from 5-10 April 2024 in San Diego. DDW’s Megan Thomas spoke with Dr Paul Moore, Chief Scientific Officer at Zymeworks and Dr Nina Weisser, Director of Multispecific Antibody Therapeutics at Zymeworks, about the event as well as the… Read More

#Cancer Research #Exclusive Content

Gastrointestinal tract
#Cancer #Clinical trials #Drug development #ESMO #Gastrointestinal #Redx Pharma #Wnt inhibition

Redx Pharma reports on zamaporvint cancer treatment trials 

Redx Pharma has announced data from all Phase II clinical trial modules of zamaporvint (RXC004), a potent, selective, orally-active Porcupine inhibitor in development for Wnt-ligand dependent, hard-to-treat gastrointestinal (GI) cancers.   These data, presented at the European Society for Medical Oncology Gastrointestinal Cancers (ESMO GI) Congress, were from… Read More

#Cancer Research #News

#Assays #Case study #Drug development #Drug discovery #iPSC #Neurology

Case Study: Consistent assays for neurological drug development

A new Case Study is now available to download for free entitled ‘Improving physiological relevance in neurological disease drug development.’ In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop… Read More

#News

Case Study: Improving physiological relevance in neurological disease drug development
#Assays #Drug development #Drug discovery #iPSC #Neurology

Improving physiological relevance in neurological disease drug development

In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped… Read More

#Resources

Bacteria in Petri dishes
#Drug development #Drug discovery #eBook #Stability characterisation #Testing

New eBook: Enhance your knowledge of drug stability testing

Learn about the key principles, methodologies and regulatory requirements of drug stability testing in a new eBook from Thermo Fisher Scientific: ‘Drug Stability Testing 101‘. The eBook has been prepared by scientists and industry professionals to provide readers with valuable insights and practical knowledge to help optimise… Read More

#News

Drug stability testing eBook
#Drug development #Drug discovery #Stability characterisation #Testing

Drug Stability Testing 101

Learn about the key principles, methodologies and regulatory requirements of drug stability testing with our recently developed eBook: ‘Drug Stability Testing 101’. This eBook has been prepared by scientists and industry professionals at Thermo Fisher Scientific to provide you with valuable insights and practical knowledge to help you optimise this critical… Read More

#Resources

#Cancer research #Drug development #Drug discovery #Guide

DDW Global Cancer Research Guide 2024

Download the exclusive Guide and read about: Where is the global innovation and opportunity in cancer drug discovery? How is technology expediting the development of new cancer drugs? CRISPR-Cas and its use in cancer research What lies ahead for cancer research?… Read More

#DDW eBooks #DDW Guides

#AI #Cancer research #Collaboration #Drug development #Lantern Pharma #Metabolic inhibitor #Oregon Therapeutics #Protein disulfide isomerase (PDI)

AI collaboration to optimise development of cancer inhibitor drug 

Lantern Pharma has entered a strategic AI-driven collaboration with French biotechnology company Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase (PDI)1 inhibitor drug candidate XCE853 in novel and targeted cancer indications.   Lantern will be leveraging its RADR AI platform to uncover biomarkers and… Read More

#Business & Investment #Cancer Research #News

#Bioprinting #Cancer research #Cancer Research Horizons #Cancer Research UK #Cell therapy #Data #Data management #Data security #Drug development #Drug discovery #Electronic Lab Notebooks (ELN) #Laboratory data #Oncology #Organ manufacturing #Start-ups #Tissue engineering

Podcast looks behind the scenes of the drug discovery industry

This is the latest episode of the free DDW narrated podcast, titled “A look behind the scenes of the drug discovery industry” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Going paperless – the move to electronic lab… Read More

#News

#Cell line development #Cell lines #Drug development

Advancing stability in cell line development 

Roxana McCloskey, Senior Global Marketing Manager, Protein Therapeutics, SCIEX explores how innovative analytical approaches can help improve stability for cell line development.   Cell line development (CLD) is a critical stage in the early production of biotherapeutic molecules. During the CLD stage, a key goal is to… Read More

#Exclusive Content